281 related articles for article (PubMed ID: 8523343)
1. Autoantibodies in systemic lupus erythematosus and urticarial vasculitis.
D'Cruz DP; Wisnieski JJ; Asherson RA; Khamashta MA; Hughes GR
J Rheumatol; 1995 Sep; 22(9):1669-73. PubMed ID: 8523343
[TBL] [Abstract][Full Text] [Related]
2. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
Wisnieski JJ; Jones SM
J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
[TBL] [Abstract][Full Text] [Related]
3. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.
Wisnieski JJ; Jones SM
J Rheumatol; 1992 Jun; 19(6):884-8. PubMed ID: 1404125
[TBL] [Abstract][Full Text] [Related]
4. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India.
Dincy CV; George R; Jacob M; Mathai E; Pulimood S; Eapen EP
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):789-94. PubMed ID: 18331318
[TBL] [Abstract][Full Text] [Related]
6. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.
Carvalho D; Savage CO; Isenberg D; Pearson JD
Arthritis Rheum; 1999 Apr; 42(4):631-40. PubMed ID: 10211876
[TBL] [Abstract][Full Text] [Related]
7. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
[TBL] [Abstract][Full Text] [Related]
8. Hypocomplementemic urticarial vasculitis: a rare presentation of systemic lupus erythematosus.
Aydogan K; Karadogan SK; Adim SB; Tunali S
Int J Dermatol; 2006 Sep; 45(9):1057-61. PubMed ID: 16961508
[TBL] [Abstract][Full Text] [Related]
9. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
10. Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.
Jönsson G; Sjöholm AG; Truedsson L; Bengtsson AA; Braconier JH; Sturfelt G
Rheumatology (Oxford); 2007 Jul; 46(7):1133-9. PubMed ID: 17478473
[TBL] [Abstract][Full Text] [Related]
11. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
[TBL] [Abstract][Full Text] [Related]
12. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
Sjoholm AG; Martensson U; Sturfelt G
J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
[TBL] [Abstract][Full Text] [Related]
13. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus?
Trendelenburg M; Courvoisier S; Späth PJ; Moll S; Mihatsch M; Itin P; Schifferli JA
Am J Kidney Dis; 1999 Oct; 34(4):745-51. PubMed ID: 10516358
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of antiepithelial cell antibody in systemic vasculitis and identification of the target antigen thereof].
Zheng WJ; Tang FL; Zhao Y; Chen H; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3272-6. PubMed ID: 16409818
[TBL] [Abstract][Full Text] [Related]
15. [Ecchymotic angioedema revealing childhood systemic lupus erythematosus with anti-C1q antibodies].
Frot AS; Barbarot S; Poignant S; Guyot C; Stalder JF
Ann Dermatol Venereol; 2008; 135(8-9):584-6. PubMed ID: 18789294
[TBL] [Abstract][Full Text] [Related]
16. Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy.
Mendonca LL; Khamashta MA; Cuadrado MJ; Bertolaccini ML; Hughes GR
Arthritis Rheum; 2000 Jul; 43(7):1511-5. PubMed ID: 10902753
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
18. [Urticarial vasculitis syndrome. A case report and review of the literature].
Iannello S; Asmundo GO; Cataliotti A; Floridia S; Loreno M; Trovato G; Vintaloro G; Belfiore F
Minerva Med; 1997 Nov; 88(11):459-67. PubMed ID: 9454098
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
20. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
Kohro-Kawata J; Wener MH; Mannik M
J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
